Treatment-Resistant Late-Life Depression: A Review of Clinical Features, Neuropsychology, Neurobiology, and Treatment.
Psychiatr Clin North Am
; 46(2): 371-389, 2023 06.
Article
in English
| MEDLINE | ID: covidwho-2326496
ABSTRACT
Major depression is common in older adults (≥ 60 years of age), termed late-life depression (LLD). Up to 30% of these patients will have treatment-resistant late-life depression (TRLLD), defined as depression that persists despite two adequate antidepressant trials. TRLLD is challenging for clinicians, given several etiological factors (eg, neurocognitive conditions, medical comorbidities, anxiety, and sleep disruption). Proper assessment and management is critical, as individuals with TRLLD often present in medical settings and suffer from cognitive decline and other marks of accelerated aging. This article serves as an evidence-based guide for medical practitioners who encounter TRLLD in their practice.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Depression
/
Depressive Disorder, Major
Type of study:
Diagnostic study
/
Etiology study
/
Prognostic study
/
Qualitative research
Topics:
Long Covid
Limits:
Aged
/
Humans
Language:
English
Journal:
Psychiatr Clin North Am
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS